Connection
Jacob Painter to Case-Control Studies
This is a "connection" page, showing publications Jacob Painter has written about Case-Control Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.611 |
|
|
|
-
Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors. Clin Breast Cancer. 2023 08; 23(6):598-619.
Score: 0.174
-
Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain. J Cancer Surviv. 2024 Jun; 18(3):917-927.
Score: 0.171
-
Stolarz AJ, Lakkad M, Klimberg VS, Painter JT. Calcium Channel Blockers and Risk of Lymphedema among Breast Cancer Patients: Nested Case-Control Study. Cancer Epidemiol Biomarkers Prev. 2019 Nov; 28(11):1809-1815.
Score: 0.134
-
Chopra DA, Shah AB, Vadhariya AH, Painter JT. The risk of varenicline-induced seizure among those who have attempted to quit smoking using pharmacotherapy. Epilepsy Behav. 2019 08; 97:169-173.
Score: 0.133